UK drugs boss faces jail over opioid scandal

A day after quitting as CEO of London-listed Indivior, Shaun Thaxter pleaded guilty to a criminal charge related to sales of opioid addiction treatments. It followed a US Department of Justice probe which accuses Indivior of fraudulently marketing the drug suboxone.